| Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial N Sprigg, K Flaherty, JP Appleton, RAS Salman, D Bereczki, M Beridze, ... The Lancet 391 (10135), 2107-2115, 2018 | 439 | 2018 |
| Primary stroke prevention worldwide: translating evidence into action MO Owolabi, AG Thrift, A Mahal, M Ishida, S Martins, WD Johnson, ... The Lancet Public Health 7 (1), e74-e85, 2022 | 306 | 2022 |
| Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 187 | 2019 |
| Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge, L Cala, M Dixon, ... The Lancet 393 (10175), 1009-1020, 2019 | 166 | 2019 |
| Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART … RAS Salman, DP Minks, D Mitra, MA Rodrigues, P Bhatnagar, ... The Lancet Neurology 18 (7), 643-652, 2019 | 89 | 2019 |
| Noncontrast CT signs as predictors of hematoma expansion, clinical outcome and response to tranexamic acid in acute ICH ZK Law, A Azlinawati, K Krishnan, A Bischoff, JP Appleton, P Scutt, ... Stroke 51 (1), 121-128, 2019 | 68* | 2019 |
| Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission VL Feigin, MO Owolabi, F Abd-Allah, RO Akinyemi, NV Bhattacharjee, ... The Lancet Neurology 22 (12), 1160-1206, 2023 | 67 | 2023 |
| Haemostatic therapies for acute spontaneous intracerebral haemorrhage RAS Salman, ZK Law, PM Bath, T Steiner, N Sprigg Cochrane Database of Systematic Reviews, 2018 | 65 | 2018 |
| Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non … RAS Salman, C Keerie, J Stephen, S Lewis, J Norrie, MS Dennis, ... The Lancet Neurology 20 (10), 842-853, 2021 | 63 | 2021 |
| Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: protocol for a randomized, placebo-controlled trial N Sprigg, K Robson, P Bath, R Dineen, I Roberts, T Robinson, C Roffe, ... International journal of stroke 11 (6), 683-694, 2016 | 54 | 2016 |
| Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease LNM Abdul Wahid SF, Law ZK, Ismail NA Cochrane Database Syst Rev 12, CD011742, 2019 | 48 | 2019 |
| Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: the … GW Blair, JP Appleton, K Flaherty, F Doubal, N Sprigg, R Dooley, ... EClinicalMedicine 11, 34-43, 2019 | 45 | 2019 |
| Quantitative CT radiomics-based models for prediction of haematoma expansion and poor functional outcome in primary intracerebral haemorrhage S Pszczolkowski, JP Manzano-Patrón, ZK Law, K Krishnan, A Ali, PM Bath, ... European radiology 31, 7945-7959, 2021 | 44 | 2021 |
| Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data TJ Moullaali, X Wang, EC Sandset, LJ Woodhouse, ZK Law, H Arima, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (1), 6-13, 2022 | 41 | 2022 |
| Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage: extended follow-up of the RESTART randomized clinical trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... JAMA neurology 78 (10), 1179-1186, 2021 | 39 | 2021 |
| The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on … ZK Law, HJ Tan, SP Chin, CY Wong, WNNW Yahya, AS Muda, R Zakaria, ... Cytotherapy 23 (9), 833-840, 2021 | 37 | 2021 |
| The role of EEG in the diagnosis, prognosis and clinical correlations of dementia with Lewy bodies—a systematic review ZK Law, C Todd, R Mehraram, J Schumacher, MR Baker, FEN LeBeau, ... Diagnostics 10 (9), 616, 2020 | 32 | 2020 |
| Predictors and outcomes of neurological deterioration in intracerebral hemorrhage: results from the TICH-2 randomized controlled trial ZK Law, R Dineen, TJ England, L Cala, AK Mistri, JP Appleton, S Ozturk, ... Translational Stroke Research 12, 275-283, 2021 | 29 | 2021 |
| Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial … GW Blair, JP Appleton, ZK Law, F Doubal, K Flaherty, R Dooley, K Shuler, ... International Journal of Stroke 13 (5), 530-538, 2018 | 29 | 2018 |
| Treatment of intracerebral haemorrhage with tranexamic acid–a review of current evidence and ongoing trials ZK Law, A Meretoja, ST Engelter, H Christensen, EM Muresan, SB Glad, ... European stroke journal 2 (1), 13-22, 2017 | 29 | 2017 |
Nikola SpriggUniversity of NottinghamVerified email at nottingham.ac.uk
